Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Avery August

Showing results (131-140 of 146) with videos related to

Pageof 15
Sort By:
Science Advances|January 3, 2024
Adaptive immune cells are necessary for SARS-CoV-2-induced pathologyBrian Imbiakha, Julie M Sahler, David W Buchholz, et al.
FASEB Journal : Official Publication of the Federation of American Societies for Experimental Biology|October 4, 2015
The origin and implementation of the Broadening Experiences in Scientific Training programs: an NIH common fund initiativeFrederick J Meyers, Ambika Mathur, Cynthia N Fuhrmann, et al.
Biomedicine & Pharmacotherapy = Biomedecine & Pharmacotherapie|November 22, 2023
Targeting kinase ITK treats autoimmune arthritis via orchestrating T cell differentiation and functionYe Chen, Rongzhen Liang, Xiaoyi Shi, et al.
Biorxiv : the Preprint Server for Biology|August 7, 2023
Endothelial SARS-CoV-2 infection is not the underlying cause of COVID19-associated vascular pathology in miceSiqi Gao, Alan T Tang, Min Wang, et al.
Frontiers in Cardiovascular Medicine|October 12, 2023
Endothelial SARS-CoV-2 infection is not the underlying cause of COVID-19-associated vascular pathology in miceSiqi Gao, Alan T Tang, Min Wang, et al.
Science Advances|September 22, 2023
Age-dependent acquisition of pathogenicity by SARS-CoV-2 Omicron BA.5Brian Imbiakha, Shahrzad Ezzatpour, David W Buchholz, et al.
Biochemical and Biophysical Research Communications|February 19, 2025
Novel nanobody drug conjugate as a prophylactic or therapeutic against SARS-CoV-2 infection in miceBrian Imbiakha, Shahrzad Ezzatpour, David W Buchholz, et al.
The Journal of Clinical Investigation|November 26, 2024
IL-2-inducible T cell kinase deficiency sustains chimeric antigen receptor T cell therapy against tumor cellsZheng Fu, Zineng Huang, Hao Xu, et al.
Biorxiv : the Preprint Server for Biology|December 15, 2021
SARS-CoV-2 infection of olfactory epithelial cells and neurons drives acute lung injury and lethal COVID-19 in miceAlan T Tang, David W Buchholz, Katherine M Szigety, et al.
Plos Biology|February 6, 2023
Cell-autonomous requirement for ACE2 across organs in lethal mouse SARS-CoV-2 infectionAlan T Tang, David W Buchholz, Katherine M Szigety, et al.
Pageof 15

Showing results (131-140 of 146) with videos related to

Sort By:
Pageof 15
Science Advances|January 3, 2024
Adaptive immune cells are necessary for SARS-CoV-2-induced pathologyBrian Imbiakha, Julie M Sahler, David W Buchholz, et al.
FASEB Journal : Official Publication of the Federation of American Societies for Experimental Biology|October 4, 2015
The origin and implementation of the Broadening Experiences in Scientific Training programs: an NIH common fund initiativeFrederick J Meyers, Ambika Mathur, Cynthia N Fuhrmann, et al.
Biomedicine & Pharmacotherapy = Biomedecine & Pharmacotherapie|November 22, 2023
Targeting kinase ITK treats autoimmune arthritis via orchestrating T cell differentiation and functionYe Chen, Rongzhen Liang, Xiaoyi Shi, et al.
Biorxiv : the Preprint Server for Biology|August 7, 2023
Endothelial SARS-CoV-2 infection is not the underlying cause of COVID19-associated vascular pathology in miceSiqi Gao, Alan T Tang, Min Wang, et al.
Frontiers in Cardiovascular Medicine|October 12, 2023
Endothelial SARS-CoV-2 infection is not the underlying cause of COVID-19-associated vascular pathology in miceSiqi Gao, Alan T Tang, Min Wang, et al.
Science Advances|September 22, 2023
Age-dependent acquisition of pathogenicity by SARS-CoV-2 Omicron BA.5Brian Imbiakha, Shahrzad Ezzatpour, David W Buchholz, et al.
Biochemical and Biophysical Research Communications|February 19, 2025
Novel nanobody drug conjugate as a prophylactic or therapeutic against SARS-CoV-2 infection in miceBrian Imbiakha, Shahrzad Ezzatpour, David W Buchholz, et al.
The Journal of Clinical Investigation|November 26, 2024
IL-2-inducible T cell kinase deficiency sustains chimeric antigen receptor T cell therapy against tumor cellsZheng Fu, Zineng Huang, Hao Xu, et al.
Biorxiv : the Preprint Server for Biology|December 15, 2021
SARS-CoV-2 infection of olfactory epithelial cells and neurons drives acute lung injury and lethal COVID-19 in miceAlan T Tang, David W Buchholz, Katherine M Szigety, et al.
Plos Biology|February 6, 2023
Cell-autonomous requirement for ACE2 across organs in lethal mouse SARS-CoV-2 infectionAlan T Tang, David W Buchholz, Katherine M Szigety, et al.
Pageof 15